+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents



Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents



Current Drug Targets 8(3): 399-411



Tuberculosis (TB) and Malaria are neglected diseases, which continue to be major causes of morbidity and mortality worldwide, killing together around 5 million people each year. Mycolic acids, the hallmark of mycobacteria, are high-molecular-weight alpha-alkyl, beta-hydroxy fatty acids. Biochemical and genetic experimental data have shown that the product of the M. tuberculosis inhA structural gene (InhA) is the primary target of isoniazid mode of action, the most prescribed anti-tubercular agent. InhA was identified as an NADH-dependent enoyl-ACP(CoA) reductase specific for long-chain enoyl thioesters and is a member of the Type II fatty acid biosynthesis system, which elongates acyl fatty acid precursors of mycolic acids. M. tuberculosis and P. falciparum enoyl reductases are targets for the development of anti-tubercular and antimalarial agents. Here we present a brief description of the mechanism of action of, and resistance to, isoniazid. In addition, data on inhibition of mycobacterial and plasmodial enoyl reductases by triclosan are presented. We also describe recent efforts to develop inhibitors of M. tuberculosis and P. falciparum enoyl reductase enzyme activity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048959709

Download citation: RISBibTeXText

PMID: 17348833


Related references

Enoyl Reductases as Targets for the Development of Anti-Tubercular and Anti-Malarial Agents. Current Drug Targets 8(3): 399-411, 2007

Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. European Journal of Medicinal Chemistry 163: 404-412, 2018

Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi. Organic and Biomolecular Chemistry 9(2): 400-407, 2011

Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives. Bioorganic and Medicinal Chemistry Letters 26(9): 2245-2250, 2016

Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents. Journal of Enzyme Inhibition and Medicinal Chemistry 30(6): 1027-1033, 2016

Molecular modeling of drug-pathophysiological Mtb protein targets: Synthesis of some 2-thioxo-1, 3-thiazolidin-4-one derivatives as anti-tubercular agents. Journal of Molecular Structure 1147: 682-696, 2017

Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Bioorganic and Medicinal Chemistry 14(3): 650-658, 2005

Synthesis of substituted benzothiazolyl guanidines as anti bacterial and anti tubercular agents. Indian Journal of Pharmacy 31(3): 81-83, 1969

Positioning of various anti-bacterial agents and their appropriate use in the era of multiple drug resistance. 10. Anti-tubercular drugs. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 92(11): 2165-2169, 2003

Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents. European Journal of Medicinal Chemistry 146: 747-756, 2018

ProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents. Bioorganic and Medicinal Chemistry 22(9): 2816-2824, 2014

Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives. Current Medicinal Chemistry 22(38): 4379-4397, 2016

Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents. Bioorganic and Medicinal Chemistry 12(4): 683-692, 2004

Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chemical Society Reviews 39(2): 435-454, 2010

Lincomycin part 8 4 alkyl 1 demethyl 4 depropylclindamycins potent anti bacterial and anti malarial agents. Journal Of Medicinal Chemistry: 780-784, 1969